Early Specialized Palliative Care for Unresectable Pancreatic Cancer: A Quasi-Experimental Study.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: unresectable pancreatic cancer have a poor prognosis and often high health care requirements
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
The proportion of patients who died in hospital outside the palliative care unit was significantly lower in the intervention cohort compared with the control cohort, 14.5% vs 30.5% (P = 0.035). [CONCLUSION] Early specialized palliative care for patients with unresectable pancreatic cancer resulted in an increase in survival without an increase in use of hospital care.
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.6%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
[CONTEXT] Patients with unresectable pancreatic cancer have a poor prognosis and often high health care requirements.
- 표본수 (n) 65
- p-value P = 0.029
- p-value P = 0.002
- 95% CI 5.9-10.0
APA
Dufva I, Juhl G, et al. (2026). Early Specialized Palliative Care for Unresectable Pancreatic Cancer: A Quasi-Experimental Study.. Journal of pain and symptom management, 71(3), 419-428. https://doi.org/10.1016/j.jpainsymman.2025.11.025
MLA
Dufva I, et al.. "Early Specialized Palliative Care for Unresectable Pancreatic Cancer: A Quasi-Experimental Study.." Journal of pain and symptom management, vol. 71, no. 3, 2026, pp. 419-428.
PMID
41319817 ↗
Abstract 한글 요약
[CONTEXT] Patients with unresectable pancreatic cancer have a poor prognosis and often high health care requirements.
[OBJECTIVES] To evaluate the impact of early specialized palliative care for patients with unresectable pancreatic cancer on hospital use.
[METHODS] Using a quasi-experimental design, newly diagnosed patients with unresectable pancreatic cancer diagnosed from October 2019 to February 2021 were offered specialized palliative care delivered as home-visits (n = 65). The retrospective control cohort were similar patients diagnosed between December 2017 and April 2019 (n = 60). The primary endpoint was use of hospital care. Secondary outcomes included survival, quality of life and place of death.
[RESULTS] Median overall survival was significantly longer in the intervention cohort compared with the control cohort, 8.0 months (95% CI, 5.9-10.0) vs 4.9 months (95% CI, 3.5-6.3) (P = 0.029). There was no difference in use of hospital care between the cohorts, but given the longer survival in the intervention cohort there were significant reductions in monthly hospital admissions, 0.8 vs 1.2 (P = 0.002), emergency department admissions, 0.4 vs 0.6 (P = 0.009) and days in hospital, 4.2 vs 7.2 (P = 0.001) in the intervention cohort compared with the control cohort. The proportion of patients who died in hospital outside the palliative care unit was significantly lower in the intervention cohort compared with the control cohort, 14.5% vs 30.5% (P = 0.035).
[CONCLUSION] Early specialized palliative care for patients with unresectable pancreatic cancer resulted in an increase in survival without an increase in use of hospital care.
[OBJECTIVES] To evaluate the impact of early specialized palliative care for patients with unresectable pancreatic cancer on hospital use.
[METHODS] Using a quasi-experimental design, newly diagnosed patients with unresectable pancreatic cancer diagnosed from October 2019 to February 2021 were offered specialized palliative care delivered as home-visits (n = 65). The retrospective control cohort were similar patients diagnosed between December 2017 and April 2019 (n = 60). The primary endpoint was use of hospital care. Secondary outcomes included survival, quality of life and place of death.
[RESULTS] Median overall survival was significantly longer in the intervention cohort compared with the control cohort, 8.0 months (95% CI, 5.9-10.0) vs 4.9 months (95% CI, 3.5-6.3) (P = 0.029). There was no difference in use of hospital care between the cohorts, but given the longer survival in the intervention cohort there were significant reductions in monthly hospital admissions, 0.8 vs 1.2 (P = 0.002), emergency department admissions, 0.4 vs 0.6 (P = 0.009) and days in hospital, 4.2 vs 7.2 (P = 0.001) in the intervention cohort compared with the control cohort. The proportion of patients who died in hospital outside the palliative care unit was significantly lower in the intervention cohort compared with the control cohort, 14.5% vs 30.5% (P = 0.035).
[CONCLUSION] Early specialized palliative care for patients with unresectable pancreatic cancer resulted in an increase in survival without an increase in use of hospital care.